Latest Singulair news
FDA: Montelukast Tablet Bottles Recalled
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.
Montelukast Associated With Nightmares, Depression
posted September 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Montelukast appears to be linked to neuropsychiatric side effects, such as depression, aggression, nightmares, and headaches, according to a review published online Sept. 20 in Pharmacology Research and Perspectives.
Therapist-Led Online Cognitive Behavioral Therapy Aids Depression 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Bowel Urgency in Ulcerative Colitis Linked to Disease-Related Disability 
Habitual Fasting May Be Harmful for Older Adults 
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Couples" Coping Skills Help Reduce Depression in GI Cancer Survivors 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens Monthly Specialist Briefings
Stay Connected
